Cardiology

Cardiology Seminar CME / CPD 

Full Course:  20 AMA PRA Category 1 Credits for CME / CEU / CPD

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:  Cardiologists, Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)

Series 27 (CAR27) Topics Include:  Chest Pain, Treatment of Hyperlipidemia, Cardiac Care, Cardiovascular Update, Prevention to Intervention, Therapies, and more.

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Format:
Available in Audio format.

Course Topics

Advances in Cardiovascular Care

Compare outcomes of patients who have undergone stenting with those who have had coronary bypass surgery; Optimize patients with CAD for cardiac and noncardiac surgery; Explain the pharmacodynamics and means of reversal of anticoagulant medications prescribed for patients with CAD; Summarize the advantages of inhalational anesthetics for patients with CAD; Recommend an appropriate antiplatelet medication for a patient with CAD who requires surgery.

Cardiac Care: Part 1

Understand the significance of high-sensitivity troponin testing; Recognize the need for use of risk scoring in patients with a suspected acute coronary event; Select appropriate patients for the early rule-out of MI; Explain the evolution of do-not-resuscitate orders; Facilitate planning of end-of-life care.

Assessment and Management of Risk for Cardiovascular Disease

Consider the cost-effectiveness of different therapies for HTN; Implement society guidelines and recommendations for the management of HTN; Adopt strategies to improve adherence to therapy for HTN; Recommend the appropriate imaging study for patients at risk for CAD; Weigh the advantages and disadvantages of each imaging study for patients with suspected CAD.

Cardiac Care: Part 2

Identify patients who require urgent reperfusion therapy; Determine which patients should undergo primary percutaneous coronary intervention vs fibrinolysis; Decrease time between identification of STEMI and definitive treatment; Use prediction rules, eg, Wells score, in suspected pulmonary embolism; Recognize the importance of pretest probability with use of age-adjusted D-dimer testing.

Highlights from the Toronto Cardiac Tumor Conference

Recognize the difficulties involved in mounting clinical trials of treating sarcomas; Discuss the goals and requirements of neoadjuvant treatment of cardiac sarcomas; Compare systemic treatments available for metastatic or recurrent sarcomas; Summarize the characteristics of intimal sarcomas and angiosarcomas; Describe T-cell therapies for synovial sarcomas.

Cardiovascular Update

Consider the use of statins in patients with coronary artery disease; Choose appropriate antiplatelet therapy for patients post-acute coronary syndrome; Manage patients with congestive heart failure; Identify risk factors in patients with elevated triglyceride levels; Select appropriate patients for treatment with fibrates, niacin, or omega-3 fatty acids.

Treatment of Hyperlipidemia

Distinguish between the Adult Treatment Panel III guidelines and the updated American College of Cardiology/American Heart Association guidelines for treating hyperlipidemia; Select appropriate patients for treatment with high-intensity, moderate-intensity or low-intensity statins; Explain the mechanism of action of proprotein convertase subtilisin/kexin type 9 inhibitors; Choose appropriate treatment for a patient with intolerance to statin therapy; Explain the concept of reverse cholesterol transport.

From Prevention to Intervention: Keys to Improving Cardiovascular Care

Choose the appropriate treatment for a patient with familial hypercholesterolemia; Weigh the advantages and disadvantages of proprotein convertase subtilisin-kexin type 9 inhibitors; Counsel patients about using supplements, such as niacin and omega-3 fatty acids, to improve lipid profiles; Explain CV risk associated with polycystic ovary syndrome and nonalcoholic fatty liver disease; Recommend treatment for rheumatoid arthritis and psoriasis associated with the lowest risk for adverse CV outcomes.

Therapies for Cardiovascular Diseases

Distinguish between HF with reduced ejection fraction (HFrEF) and HF with preserved EF (HFpEF); Recommend the appropriate therapy for the management of HFrEF; Identify indications for referral to advanced therapies in HF; Obtain appropriate baseline studies before initiating statin therapy; Implement the algorithm for managing muscle symptoms in patients receiving statin therapy.

Chest Pain: Pointers on Improving Diagnosis

Determine which patients with chest pain require transfer to the emergency department; Recognize the importance of an accurate patient history in evaluating patients with chest pain; Use appropriate tests to screen for acute coronary syndrome and other causes of chest pain; Accurately identify life-threatening and serious causes of chest pain without overtesting or overtreating patients with less serious causes; Consider the role of anxiety when managing noncardiac chest pain.

Assessment and Management of Risk for Cardiovascular Disease

Consider the cost-effectiveness of different therapies for HTN; Implement society guidelines and recommendations for the management of HTN; Adopt strategies to improve adherence to therapy for HTN; Recommend the appropriate imaging study for patients at risk for CAD; Weigh the advantages and disadvantages of each imaging study for patients with suspected CAD.

Highlights from the Toronto Cardiac Tumor Conference

Recognize the difficulties involved in mounting clinical trials of treating sarcomas; Discuss the goals and requirements of neoadjuvant treatment of cardiac sarcomas; Compare systemic treatments available for metastatic or recurrent sarcomas; Summarize the characteristics of intimal sarcomas and angiosarcomas; Describe T-cell therapies for synovial sarcomas.

Treatment of Hyperlipidemia

Distinguish between the Adult Treatment Panel III guidelines and the updated American College of Cardiology/American Heart Association guidelines for treating hyperlipidemia; Select appropriate patients for treatment with high-intensity, moderate-intensity or low-intensity statins; Explain the mechanism of action of proprotein convertase subtilisin/kexin type 9 inhibitors; Choose appropriate treatment for a patient with intolerance to statin therapy; Explain the concept of reverse cholesterol transport.

Therapies for Cardiovascular Diseases

Distinguish between HF with reduced ejection fraction (HFrEF) and HF with preserved EF (HFpEF); Recommend the appropriate therapy for the management of HFrEF; Identify indications for referral to advanced therapies in HF; Obtain appropriate baseline studies before initiating statin therapy; Implement the algorithm for managing muscle symptoms in patients receiving statin therapy.

Chest Pain: Pointers on Improving Diagnosis

Determine which patients with chest pain require transfer to the emergency department; Recognize the importance of an accurate patient history in evaluating patients with chest pain; Use appropriate tests to screen for acute coronary syndrome and other causes of chest pain; Accurately identify life-threatening and serious causes of chest pain without overtesting or overtreating patients with less serious causes; Consider the role of anxiety when managing noncardiac chest pain.

Advances in Cardiovascular Care

Compare outcomes of patients who have undergone stenting with those who have had coronary bypass surgery; Optimize patients with CAD for cardiac and noncardiac surgery; Explain the pharmacodynamics and means of reversal of anticoagulant medications prescribed for patients with CAD; Summarize the advantages of inhalational anesthetics for patients with CAD; Recommend an appropriate antiplatelet medication for a patient with CAD who requires surgery.

Cardiac Care: Part 1

Understand the significance of high-sensitivity troponin testing; Recognize the need for use of risk scoring in patients with a suspected acute coronary event; Select appropriate patients for the early rule-out of MI; Explain the evolution of do-not-resuscitate orders; Facilitate planning of end-of-life care.

Cardiac Care: Part 2

Identify patients who require urgent reperfusion therapy; Determine which patients should undergo primary percutaneous coronary intervention vs fibrinolysis; Decrease time between identification of STEMI and definitive treatment; Use prediction rules, eg, Wells score, in suspected pulmonary embolism; Recognize the importance of pretest probability with use of age-adjusted D-dimer testing.

Cardiovascular Update

Consider the use of statins in patients with coronary artery disease; Choose appropriate antiplatelet therapy for patients post-acute coronary syndrome; Manage patients with congestive heart failure; Identify risk factors in patients with elevated triglyceride levels; Select appropriate patients for treatment with fibrates, niacin, or omega-3 fatty acids.

From Prevention to Intervention: Keys to Improving Cardiovascular Care

Choose the appropriate treatment for a patient with familial hypercholesterolemia; Weigh the advantages and disadvantages of proprotein convertase subtilisin-kexin type 9 inhibitors; Counsel patients about using supplements, such as niacin and omega-3 fatty acids, to improve lipid profiles; Explain CV risk associated with polycystic ovary syndrome and nonalcoholic fatty liver disease; Recommend treatment for rheumatoid arthritis and psoriasis associated with the lowest risk for adverse CV outcomes.

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include: Internal Medicine, Family Practice, Women's Health, Men's Health, and Geriatrics

If you have taken the current Cardiology CME Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon. There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.